New Recommendations Say All Babies Need Delayed Cord Clamping

Feb 20 9:00am Pregnancy – EverydayFamily
EverydayFamily - Pregnancy, Baby, Child Information, Parenting Community, EverydayFamily If you're preparing to have a baby soon, there's one important thing you need to add to your to-do list: Make sure your doctor or delivery provider will practice delayed cord clamping. ... Read More EverydayFamily - Pregnancy, Baby, Child Information, Parenting Community, EverydayFamily...
Read More
5

Arix Bioscience raises 100m in IPO

Feb 20 2:52am PBR - News
Global healthcare and life science company Arix Bioscience has raised £100m in its Initial Public Offering (IPO) on the main market of the London Stock Exchange.
Read More
7

Momenta announces FDA warning letter to contracted Glatopas fill/finish manufacturer

Feb 20 2:51am PBR - News
Momenta Pharmaceuticals has announced that Pfizer, Sandoz’s contracted Glatopa (glatiramer acetate injection) fill/finish manufacturing partner has received a warning letter from the FDA.
Read More
7

Daiichi Sankyo, ArQules tivantinib fails to meet primary end point in liver cancer study

Feb 20 2:13am PBR - News
Daiichi Sankyo and ArQule announced that the tivantinib has failed to meet its primary endpoint in a phase 3 liver cancer study.
Read More
7

Judge Rules that Two Hospitals Broke Law by Not Offering Charity Care to Patients

Feb 20 12:49am Health Watched
At long last, justice came in December 2016 for former patients at Yakima Regional Medical and Cardiac Center and Toppenish Community Hospital, both in Central Washington, when the hospitals agreed to pay $4.5 million into a settlement fund to compensate those who were wrongly denied financial  assistance from 2007-2014.  Last July, Yakima County Superior Court […]...
Read More
1

Will A 5 Minute Exercise Snack Benefit Us?

Feb 19 10:35pm Pregnancy Exercise
Let’s face it, many of us tend to be ‘time poor’, days are busy and full and if in the past (pre kids) we have been able to manage an hour of exercise doing just 5-10 minutes can often seem pointless, so we don’t bother! This week on The Cafe  I was asked if I could show their viewers a […]...
Read More
8

AstraZeneca's Lynparza meets primary endpoint in breast cancer study

Feb 19 7:00pm PBR - News
A phase 3 study of AstraZeneca’s Lynparza (olaparib) met primary endpoint in a phase III trial in BRCA-mutated metastatic breast cancer.
Read More
8

<b>Bill Gates</b> Says There???s Something Worse Than Nuclear War And We???re Not Ready For It

Feb 19 7:00pm BioSpace.com Featured News and Stories
  Life Sciences Jobs   ...
Read More
8

Bay Area's Accused Of Smuggling Hazardous Chemicals And Conspiracy To Defraud The U.S.

Feb 19 7:00pm BioSpace.com Featured News and Stories
  Life Sciences Jobs   ...
Read More

Questions Arise Over a Congressman's Ties With Australian Biotech Innate Immunotherapeutics

Feb 19 7:00pm BioSpace.com Featured News
  Life Sciences Jobs   ...
Read More
8

The 10 Biggest Losers in Biopharma Last Year

Feb 19 7:00pm BioSpace.com Featured News
  Life Sciences Jobs   ...
Read More
6

Obamacare was 'flawed', but here's what health care should look like after reform: ex-Aetna CEO

Feb 19 5:03pm Health Care
Former Aetna CEO Ron Williams weighs in on what changes could be ahead for the Affordable Care Act and consumers.
Read More
13

MD Anderson Benches IBM Watson In Setback For Artificial Intelligence In Medicine

Feb 19 3:48pm The Medicine Show
MD Anderson has placed a much-ballyhooed 'Watson for cancer' product it was developing with IBM on hold -- and is looking for a new partner.
Read More
13

Free Visual Birth Plan Template (That Nurses Wont Scoff At)

Feb 19 7:40am Pregnancy – Mama Natural
A birth plan, sometimes referred to as birthing plan, is a blueprint of what choices you and your partner have made for the arrival of your child. It also helps your birth attendants support you during your labor and delivery in the best possible way. Sounds great right? Except it’s not, because nobody cares about your birth […] The post Free Visual Birth Plan Template (That Nurses Won’t Scoff At) appeared first on Mama Natural.
Read More

UnitedHealth shares fall after Justice Department joins Medicare whistleblower lawsuit

Feb 17 2:10pm Health Care
UnitedHealth denies allegations it gamed the nation's Medicare system for hundreds of millions of dollars.
Read More
19

Mark Cuban: 'There's no chance' Republicans can accomplish their Obamacare goals

Feb 17 1:57pm Health Care
The burdens of repealing and replacing Obamacare will fall on consumers, Mark Cuban tells CNBC.
Read More
18

Why Is Tummy Time Important? 10 Tips for Tummy Time Success

Feb 17 1:19pm Pregnancy – Mama Natural
Before babies crawl and walk, they have other important physical milestones to meet like rolling over and lifting up their heads and necks. In fact, nearly all of babies “moves” are predicated by his or her regular practice of tummy time. What is tummy time and why is it important? Tummy time is exactly what it sounds […] The post Why Is Tummy Time Important? 10 Tips for Tummy Time Success appeared first on Mama Natural.
Read More
62

Bob Ehrlich of DTC Perspectives Should Do Better Research & Fact Checking Before He Calls Out Media for "Misreporting" on DTC Off-Label Promotion

Feb 17 9:52am Pharma Marketing Blog
I just received an email missive from Bob Ehrlich (@BobEhrlich\_DTC), Chairman of DTC Perspectives, Inc., with the subject line Media Misreporting Advertising Off-label Use. Ehrlich said I was shocked to see media stories saying DTC may expand to cover off label use. What! This erroneous idea came from an FDA open meeting held 11/16 to discuss off label use based on court cases allowing drug companies the right to discuss them. WRONG!I first reported that the FDA was interested in hearing comments about off-label drug promotion to patient and consumer audiences back in September, 2016, after reading this in the Federal Register Notice (read FDA May Have No Choice But to Allow Direct-to-Consumer Off-Label Drug Promotion and find the notice here):  To what extent is it appropriate for firms to communicate information about unapproved uses of their approved/cleared medical produc...
Read More
58

Vitamin D prevents colds? News stories turn blind eye to limitations of sunshine vitamin study

Feb 17 9:29am Health News Review
Vitamin D is a hot research topic, but the public gets a lot of mixed messages about its usefulness and safety. Case in point: One of the latest studies, published Wednesday, Feb. 15, analyzed results from 25 previous trials and found that vitamin D supplementation might help prevent respiratory infections in some people who have low […]...
Read More
20

Compound &amp; BioSample Management 2017 Market Trend Report

Feb 17 8:37am RSS Feed
Compound management and biological sample management both have significant influence in the drug discovery process. Compounds of a high integrity contribute to reliable results when locating drug candidates. Additionally, the collection, storage and distribution of human biological materials...
Read More
24

Pharma CEOs Speak Out About Drug Prices

Feb 17 7:02am Pharma Marketing Blog
Pharmaguy’s Selected List of Pharma CEOs’ Words of Wisdom Regarding Drug Prices, Jobs, and Taxes CEOs include: PHARMA BRO’ MARTIN SHKRELIALLERGAN CEO BRENT SAUNDERSPFIZER CEO IAN READMYLAN CEO HEATHER BRESCHMARATHON CEO JEFF ARONINLILLY CEO DAVID RICKSREGENERON CEO LEONARD SCHLEIFERNOVARTIS CEO JOESEPH JIMENEZACORDIA CEO RON COHEN Pharma CEOs Speak Out About Drug Prices from PharmaGuy.com...
Read More
20

DNA computer brings 'intelligent drugs' a step closer

Feb 17 6:50am Nanowerk Biotech News
Researchers present a new method that should enable controlled drug delivery into the bloodstream using DNA computers.            ...
Read More
19

Company Spotlight: Pulse Biosciences

Feb 17 5:16am RTT - Biotech
Shares of development-stage medical technology company Pulse Biosciences Inc. (PLSE) have gained nearly 30\% so far this week.
Read More
21

Valeant gets FDA approval for SILIQ to treat moderate-to-severe plaque psoriasis

Feb 17 4:16am PBR - News
The US Food and Drug Administration (FDA) has approved Valeant Pharmaceuticals International's Biologics License Application (BLA) for SILIQ (brodalumab) injection, for subcutaneous use, a monoclonal antibody that targets the IL-17 receptor for patients with moderate-to-severe plaque psoriasis.
Read More
20

Takeda acquires Ariad Pharmaceuticals

Feb 17 4:14am PBR - News
Takeda Pharmaceutical has completed its acquisition of Ariad Pharmaceuticals for $24.00 per share in cash.
Read More
19

Gainers & Losers Of The Day: CRSP, XTLB, CRSP, ACUR, EVOK...

Feb 17 1:10am RTT - Biotech
Neuralstem Inc.'s phase 2 trial of NSI-189 for the treatment of major depressive disorder has been completed ahead of schedule.
Read More
28

Pfizers rheumatoid arthritis drug shows treatment benefit in combination but not alone

Feb 17 12:53am PBR - News
Pfizer’s phase 3B/4 study evaluating its Xeljanz (tofacitinib citrate) drug, a treatment for moderate to severe rheumatoid arthritis (RA), met its primary endpoint in combination with methotrexate (MTX) against AbbVie's adalimumab (Humira) but didn't meet the primary endpoint on its own.
Read More
21

Week 21: The old and the new

Feb 16 11:00pm Knocked Up – Pregnancy & Newborn Magazine
I’m having my third boy in a row, so you might think I already have all the boy supplies I could possibly need. Like Ariel, “Wouldn’t you think I’m the girl; the girl who has … everything?” And I do … Continue reading → The post Week 21: The old and the new appeared first on Pregnancy & Newborn Magazine.
Read More
23

Alexion's Bloated Blockbuster Deal Still Haunts

Feb 16 7:00pm BioSpace.com Featured News and Stories
  Life Sciences Jobs   ...
Read More
63

How Much Money Embattled Theranos Has Left in the Bank

Feb 16 7:00pm BioSpace.com Featured News
  Life Sciences Jobs   ...
Read More
66

Takeover Candidate Alexion Is On The Mend

Feb 16 7:00pm BioSpace.com Featured News and Stories
  Life Sciences Jobs   ...
Read More
64

Woman to Watch: Meet the Woman Who is Helming Boston's Cocoon Biotech

Feb 16 7:00pm BioSpace.com Featured News
  Life Sciences Jobs   ...
Read More
63

Addendum: Capacity Utilization and Fed Surveys

Feb 16 6:34pm
Two updates from my just-published post: First, I mentioned capacity utilization, here’s the data (see graphs below). I’m simply noting the data are mixed, and this hard data point does not (yet) reflect the enthusiasm I’m seeing in the Fed… Read more → The post Addendum: Capacity Utilization and Fed Surveys appeared first on Quintessential.
Read More
13

VIDEO Tracing the origins of Obamacare confusion: Study highlights role of politicized local TV news coverage

Feb 16 4:59pm Health News Review
During the first open enrollment for the Affordable Care Act (ACA; also called “Obamacare”) back in 2013-2014 most people were getting information regarding the law’s health insurance options from local television news, but that news coverage was highly politicized and rarely included information consumers needed to make an informed choice. A study published today in the  American Journal of Public […]...
Read More
135

Obamacare plans coming soon GOP vows as Dems grill Trump's big health-care pick

Feb 16 4:46pm Health Care
House Speaker Paul Ryan said they plan to introduce legislation as early as next Tuesday.
Read More
16

Are EMFs Real?

Feb 16 1:17pm Pregnancy – Mama Natural
You can’t see them. Can’t hear them. Can’t smell them. Most people can’t feel them. So are EMFs actually a thing? Well, I just rented a couple meters, so in this video and post, we’ll find out. Before we start – a special gift for you Want to protect your family from harmful EMF exposure? Download […] The post Are EMFs Real? appeared first on Mama Natural.
Read More
83

Tilray grows capacity in North America's only GMP cannabis facility

Feb 16 11:04am in-PharmaTechnologist RSS
Medical cannabis supplier Tilray has expanded its formulary team and mooted the idea of extending its distribution network just weeks after the EMA granted its Canadian production site GMP accreditation.
Read More
80

16 Parents Share Their First Thought When They Realized They Were Pregnant

Feb 16 9:00am Pregnancy – EverydayFamily
EverydayFamily - Pregnancy, Baby, Child Information, Parenting Community, EverydayFamily I can still remember it like it was yesterday, taking the pregnancy test and wondering if it was finally going to show up with two lines. I can remember that moment each time I found out I was pregnant and those first thoughts of both extreme excitement and wonderment ... Read More EverydayFamily - Pregnancy, Baby, Child Information, Parenting Community, EverydayFamily...
Read More
20

Data That is Catching My Eye

Feb 16 8:42am
Federal Reserve surveys capture sentiment. They are reported monthly. Recently they have moved strongly higher. These moves higher are impressive. Businesses are saying that times are good. That sentiment seems to be reflected in stock markets. As I try to… Read more → The post Data That is Catching My Eye appeared first on Quintessential.
Read More
18

WE HAVE SOMETHING TO REVEAL!

Feb 16 8:31am Destination Maternity Blog
Gender reveal parties are becoming as big or bigger than baby showers, without the pressure, but with all the excitement. There are so many ways to announce whether or not baby is going to be a boy or girl and we are the place to come for that inspiration. Let us be the source of […]...
Read More
78

Retail Clinic Check Up: CVS Retrenches, Walgreens Outsources, Kroger Expands

Feb 16 7:30am Drug Channels
Retail clinics focus on convenient care for simple acute conditions. They exemplify how drugstores and other retail outlets are broadening their services to emphasize non-dispensing revenues. As I predicted last year, clinic growth stalled in 2016. From 2010 to 2015, the number of retail clinics grew by nearly 70\%, to more than 2,000 locations. As of January 2017, the number of retail clinics was unchanged compared from the 2016 figure.Below, I update our analysis of the chains with the biggest clinic market share: CVS Health, HEB, Kroger, Rite Aid, Walgreens, and Walmart. As you will see, strategies and growth rates differ.FYI, this post is adapted from Section 1.4.1. of our 2017 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers. Friendly reminder: Discounted pricing for the report ends tomorrow!Read more »Copyright © 2006-2017 Pembroke Consulting, Inc. and Copyright ©...
Read More
18

Is the return of the one-stop-shop model just a CMO marketing ploy?

Feb 16 6:58am in-PharmaTechnologist RSS
End-to end service offerings are a differentiator within the fragmented CMO industry and not driven by pharma demand, a Results Healthcare report says.
Read More
84

Pfizer, Flynn appeal against UK regulator's 89.4m fine for epilepsy drug price hike

Feb 16 4:51am PBR - News
Pfizer and Flynn Pharma have appealed against the £89.4m fine imposed by the UK Competition and Markets Authority (CMA) for charging excessive and unfair prices for an anti-epilepsy drug.
Read More
21

ARDX Kidney Drug Passes Phase 3 Study, EDIT Up On CRISPR News, FDA Nod For VRX

Feb 16 4:31am RTT - Biotech
Ardelyx Inc.'s (ARDX) phase III clinical trial of Tenapanor as a treatment for hyperphosphatemia in patients with end-stage renal disease who are on dialysis has met its primary endpoint and was generally well-tolerated.
Read More
22

Versant Ventures launches biotechnology firm Jecure Therapeutics

Feb 16 4:06am PBR - News
Versant Ventures has launched Jecure Therapeutics, a biotechnology firm focused on the discovery of novel therapeutics to treat non-alcoholic steatohepatitis (NASH) and liver fibrosis.
Read More
22

X-Chem, Janssen extend inflammatory disease collaboration

Feb 16 3:49am PBR - News
X-Chem has expanded its collaboration with Janssen Biotech for the discovery of new drug leads for inflammatory disease treatment.
Read More
20

Ardelyx's tenapanor shows significant effect in hyperphosphatemia in phase 3 trial

Feb 16 12:55am PBR - News
A phase 3 trial evaluating Ardelyx's tenapanor, a novel treatment for hyperphosphatemia in patients with end-stage renal disease (ESRD) on dialysis, met its primary endpoint of significant difference in serum phosphorus levels.
Read More
20

Gainers & Losers Of The Day: ZSAN, EVOK, ARDX, EARS, NEOT...

Feb 15 8:15pm RTT - Biotech
Ardelyx Inc.'s phase III trial of Tenapanor as a treatment for hyperphosphatemia in patients with end-stage renal disease who are on dialysis has met its primary endpoint.
Read More
23

Alexion Stops Work on Early-Stage Sanfilippo B Drug, Takes a $85 Million Write Off

Feb 15 7:00pm BioSpace.com Featured News and Stories
  Life Sciences Jobs   ...
Read More
86

AMAG to Hire 150 New Sales Rep to Support New Drug Intrarosa

Feb 15 7:00pm BioSpace.com Featured News
  Life Sciences Jobs   ...
Read More
78

AMAG to Hire 150 New Sales Reps to Support New Drug Intrarosa

Feb 15 7:00pm BioSpace.com Featured News
  Life Sciences Jobs   ...
Read More
83

An Irreverant Guide To Winners And Losers In The CRISPR Patent Fight

Feb 15 7:00pm BioSpace.com Featured News and Stories
  Life Sciences Jobs   ...
Read More
75

3 Stocks To Check Out For Rookie Biotech Investors

Feb 15 7:00pm BioSpace.com Featured News and Stories
  Life Sciences Jobs   ...
Read More
82

The Winners And Losers In The CRISPR Patent Fight

Feb 15 7:00pm BioSpace.com Featured News and Stories
  Life Sciences Jobs   ...
Read More
83

Broad Institute/MIT/Harvard CRISPR Patents Survive PTO Interference

Feb 15 6:28pm Biotechnology Patent Law Blog | Patents4Life by Warren Woessner
Yesterday, the PTAB in interference 106,048 issued a short order finding no interference- in- fact between the claims of 12 Broad Institute patents (US Patent Number 8,697,359 et al.) and the application held by  The Regents of the University of California … Continue reading → The post Broad Institute/MIT/Harvard CRISPR Patents Survive PTO Interference appeared first on Patents4Life | Warren Woessner.
Read More
18

National health spending reached $3.4 trillion last year, and it's about to grow at a faster rate

Feb 15 4:00pm Health Care
Spending on health nationally grew by an estimated 4.8 percent in 2016, but is expected to rise at a quicker pace through 2025.
Read More
21